Ships Remplir devices to Ukraine for humanitarian nerve repair aid
Australian corporate donors agreed to buy 100 Remplir devices at humanitarian pricing for shipment to Ukraine; Orthocell donated a further 100 devices and Ukraine Crisis Appeal pledged A$10K. - Initial humanitarian shipment was delivered in April 2025; devices have been used in severe trauma injuries from the conflict, including peripheral nerve injuries associated with amputations, blast trauma, and nerve crush injuries. - Remplir is FDA-cleared and cleared for use and sale in Australia, New Zealand, Canada, Singapore, Thailand, and Hong Kong SAR; EU and UK regulatory approvals are expected in late 2026.
Australian corporate donors agreed to buy 100 Remplir devices at humanitarian pricing for shipment to Ukraine; Orthocell donated a further 100 devices and Ukraine Crisis Appeal pledged A$10K. - Initial humanitarian shipment was delivered in April 2025; devices have been used in severe trauma injuries from the conflict, including peripheral nerve injuries associated with amputations, blast trauma, and nerve crush injuries. - Remplir is FDA-cleared and cleared for use and sale in Australia, New Zealand, Canada, Singapore, Thailand, and Hong Kong SAR; EU and UK regulatory approvals are expected in late 2026.